ISRCTN49492872已完成3 期
A comparison of the effects of insulin Detemir with insulin Glargine on weight gain in female adolescents and young adults with type 1 diabetes on a basal bolus regime
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 97
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Type 1 diabetes (T1D) duration greater than 1 year or C peptide negative
- •2. Females, postmenarchal, 13 - 20 years of age
- •3. HbA1c less than 12%
- •4. Body mass index (BMI) SDS less than or equal to +2.5
- •5. On basal bolus regime
- •6. No active or untreated concurrent disease
排除标准
- •1. Non-T1D including those secondary to chronic disease
- •2. Any other physical or psychological disease likely to interfere with the normal conduct of the study and intepretation of the study results
- •3. Pregnant or breastfeeding women
- •4. Females of reproductive age who are unwilling to take appropriate measures of contraception
研究者
相似试验
进行中（未招募）
1 期
A comparison of the effects of insulin Detemir with insulin Glargine on weight gain in female adolescents and young adults with Type 1 Diabetes (T1D) on a basal bolus regime - A comparison of Insulins Detemir and Glargine in Girls with DiabetesMedDRA version: 9.1 Level: LLT Classification code 10045228 Term: Type I diabetes mellitusType 1 diabetesEUCTR2007-004144-74-GBCambridge University Hospitals NHS Foundation Trust97
进行中（未招募）
不适用
Comparison of the effect of insulin detemir and NPH insulin on dawn phenomenon in patients with Type 1 diabetes An open-labelled, randomised, cross-over, multi-center trial comparing the effect of insulin detemir versus NPH insulin as basal insulins on dawn phenomenon and the glycaemic control in patients with Type 1 diabetes treated on a basal-bolus regimen - Dawn phenomenon – insulin detemirType 1 diabetes mellitus, dawn phenomenonEUCTR2005-003877-26-HUational Centre for Diabetes Care, 1st Dept. Medicine, Diabetes Unit
进行中（未招募）
1 期
The effect of insulin detemir in combination with liraglutide and metformin compared to liraglutide and metformin in subjects with type 2 diabetes. A 26-week, randomised, open-label, parallel-group, multicentre, multinational trial with a 26-week extensioType 2 diabetesMedDRA version: 9.1 Level: LLT Classification code 10045242 Term: Type II diabetes mellitusEUCTR2007-005317-19-GBovo Nordisk A/S940
进行中（未招募）
不适用
The effect of insulin detemir in combination with liraglutide and metformin compared to liraglutide and metformin in subjects with type 2 diabetes. A 26-week, randomised, open-label, parallel-group, multicentre, multinational trial with a 26-week extension - NDEUCTR2007-005317-19-ITOVO NORDISK940
进行中（未招募）
1 期
The effect of insulin detemir in combination with liraglutide and metformin compared to liraglutide and metformin in subjects with type 2 diabetes.A 26-week, randomised, open-label, parallel-group, multicentre, multinational trial with a 26-week extensioEUCTR2007-005317-19-FRovo Nordisk A/S940